Literature DB >> 28202838

Role of Ad4-binding protein/steroidogenic factor 1 in regulating NADPH production in adrenocortical Y-1 cells.

Bing Li1, Takashi Baba, Kanako Miyabayashi, Tetsuya Sato, Yuichi Shima, Tomomi Ichinose, Daisuke Miura, Yasuyuki Ohkawa, Mikita Suyama, Ken-Ichirou Morohashi.   

Abstract

Ad4-binding protein/steroidogenic factor 1 (Ad4BP/SF-1), a member of the nuclear receptor superfamily, is expressed in steroidogenic cells and regulates all steroidogenic gene expression. We recently employed mRNA and chromatin immunoprecipitation sequence (ChIP-seq) to demonstrate that Ad4BP/SF-1 directly regulates the expression of nearly all glycolytic genes. The pentose phosphate pathway (PPP) contributes to the production of nicotinamide adenine dinucleotide phosphate (NADPH). Although the expression of PPP genes and intracellular NADPH were decreased by Ad4BP/SF-1 knockdown, these genes were not the direct targets of Ad4BP/SF-1. This study therefore investigates whether Ad4BP/SF-1 directly regulates genes implicated in NADPH production. Examination of previously published data sets of mRNA sequence (mRNA-seq) and ChIP-seq strongly suggested a possibility that other NADPH-producing genes, such as malic enzyme 1 (Me1) and methylenetetrahydrofolate dehydrogenase 2 (Mthfd2), are the direct targets of Ad4BP/SF-1. Reporter gene assays and determination of intracellular NADPH concentration supported the notion that Ad4BP/SF-1 regulates NADPH production by regulating these genes. NADPH is required for macromolecule synthesis of compounds such as steroids, and for detoxification of reactive oxygen species. When synthesizing steroid hormones, steroidogenic cells consume NADPH through enzymatic reactions mediated by steroidogenic P450s. NADPH is also consumed through elimination of reactive oxygen species produced as the byproducts of the P450 reactions. Overall, Ad4BP/SF-1 potentially maintains the intracellular NADPH level through cooperative regulation of genes involved in the biological processes for consumption and supply.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28202838     DOI: 10.1507/endocrj.EJ16-0467

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  4 in total

1.  Human mitochondrial MTHFD2 is a dual redox cofactor-specific methylenetetrahydrofolate dehydrogenase/methenyltetrahydrofolate cyclohydrolase.

Authors:  Minhye Shin; Jessica Momb; Dean R Appling
Journal:  Cancer Metab       Date:  2017-12-06

2.  Intrauterine Hyponutrition Reduces Fetal Testosterone Production and Postnatal Sperm Count in the Mouse.

Authors:  Yasuko Fujisawa; Hiroyuki Ono; Alu Konno; Ikuko Yao; Hiroaki Itoh; Takashi Baba; Kenichirou Morohashi; Yuko Katoh-Fukui; Mami Miyado; Maki Fukami; Tsutomu Ogata
Journal:  J Endocr Soc       Date:  2022-02-15

Review 3.  More Than a Metabolic Enzyme: MTHFD2 as a Novel Target for Anticancer Therapy?

Authors:  Zhiyuan Zhu; Gilberto Ka Kit Leung
Journal:  Front Oncol       Date:  2020-04-28       Impact factor: 6.244

4.  Ad4BP/SF-1 regulates cholesterol synthesis to boost the production of steroids.

Authors:  Takashi Baba; Hiroyuki Otake; Miki Inoue; Tetsuya Sato; Yasuhiro Ishihara; Ju-Yeon Moon; Megumi Tsuchiya; Kanako Miyabayashi; Hidesato Ogawa; Yuichi Shima; Lixiang Wang; Ryuichiro Sato; Takeshi Yamazaki; Mikita Suyama; Masatoshi Nomura; Man Ho Choi; Yasuyuki Ohkawa; Ken-Ichirou Morohashi
Journal:  Commun Biol       Date:  2018-03-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.